This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Preliminary Program

*Program & Topics/Titles are Subject to Change 

Tuesday, July 7, 2020

  • 08:00 17:00

    Registration

  • 08:30 10:25

    Session 3: Viral Life Cycle 1 (Entry, Replication)

    8:30 - 9:00 | Plenary Lecture 4: 30 Years of HCV Virology
                           Takaji Wakita - National Institute of Infectious Diseases, Tokyo, Japan

    9:00 - 9:25 | Keynote Lecture 3: Micro-RNA during HCV Infection
                           Selena Sagan - McGill University, Montreal, Quebec, Canada

    9:25 - 10:25 | Oral Presentations selected from Abstracts (4 x 15min) 

    Dr. Selena M. Sagan, Ph.D. is an Associate Professor, Department of Microbiology & Immunology, and Associate Member of the Department of Biochemistry, McGill University. Dr. Sagan received her Ph.D. from the University of Ottawa. She completed her postdoctoral fellowship training in Department of Microbiology & Immunology at Stanford University. Dr. Sagan is currently a Canada Research Chair in RNA Biology and Viral Infections and her laboratory studies positive-strand and negative-strand RNA viruses, including those of the Flaviviridae family (including Hepatitis C virus, Dengue virus and Zika virus). The main focus of her research program is RNA-RNA and protein-RNA interactions at the host-virus interface.

     

  • 10:25 10:55

    Coffee Break

  • 10:55 12:30

    Session 4: Viral Life Cycle 2 (Translation, Assembly)

    10:55 - 11:20 | Keynote Lecture 4: The Role of Lipids and Lipid-Associated Proteins in Assembly of HCV and Flaviviruses
                               Takasuke Fukuhara

    11:20 - 12:30 | Oral Presentations selected from Abstracts (4 x 15min)

  • 12:30 14:00

    Plated Luncheon

  • 14:00 16:20

    Session 5: Tools for HCV Elimination: Diagnostics, Sequencing and Beyond

    14:00 - 14:30 | Plenary Lecture 6: Advances in HCV Diagnostics and Point of Care Testing
                               Karine Lacombe - Saint-Antoine Hospital (AP-HP), Paris, France

    14:30 - 14:55 | Keynote Lecture 5: Tracking HCV Transmission using Next Generation Sequencing
                               Rowena Bull - University of New South Wales, Sydney, Australia

    14:55 - 15:20 | Keynote Lecture 6: Integrated Data as a Driver of HCV Prevention,
                               Care and Treatment Programs and Policies

                               Mel Krajden - BC Centre for Disease Control, Vancouver, BC, Canada

    15:20 - 16:20 | Oral Presentations selected from Abstracts (4 x 15min) 

  • 16:30 16:45

    Coffee Break

  • 16:45 18:45

    Poster Session 1

    Odd Numbered Posters